Literature DB >> 17227923

How are decisions to introduce new surgical technologies made? Advanced laparoscopic surgery at a Canadian community hospital: A qualitative case study and evaluation.

Bharat Sharma1, Nathalie M Danjoux, Julie L Harnish, David R Urbach.   

Abstract

The introduction of many new surgical technologies is associated with increased costs and uncertainty regarding risks and benefits. Currently, little is known about how decisions are made regarding the adoption of surgical innovations. To study the decision-making process for adoption of advanced laparoscopic surgical procedures at a community hospital in Toronto, Canada, we used qualitative case study methods. Data were collected using semi-structured interviews with key informants. We performed a modified thematic analysis of the data, using the conceptual framework for priority setting known as accountability for reasonableness, which consists of 4 conditions: relevance, publicity, appeals, and enforcement. Several advanced laparoscopic surgical procedures were introduced at the hospital between 2000 and 2005. During that time, there was no structured, explicit process for making decisions about introducing new surgical technologies. Use of the new surgical technologies was relevant, as measured by the perception of patient benefit and alignment with the hospital's strategic priorities. There was no systematic structure in place to oversee publicity, appeals, or enforcement. The decision to adopt advanced laparoscopic surgery at a community hospital in Toronto, Canada, was made primarily on the basis of its relevance to patient care. The process for making decisions about the adoption of new surgical technologies can be improved.

Entities:  

Mesh:

Year:  2006        PMID: 17227923     DOI: 10.1177/1553350606296341

Source DB:  PubMed          Journal:  Surg Innov        ISSN: 1553-3506            Impact factor:   2.058


  7 in total

Review 1.  A comprehensive review of telementoring applications in laparoscopic general surgery.

Authors:  Stavros A Antoniou; George A Antoniou; Jan Franzen; Stefan Bollmann; Oliver O Koch; Rudolf Pointner; Frank A Granderath
Journal:  Surg Endosc       Date:  2012-02-15       Impact factor: 4.584

2.  Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology.

Authors:  Alois Gratwohl; Alvin Schwendener; Helen Baldomero; Michael Gratwohl; Jane Apperley; Dietger Niederwieser; Karl Frauendorfer
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

Review 3.  Setting Healthcare Priorities at the Macro and Meso Levels: A Framework for Evaluation.

Authors:  Edwine W Barasa; Sassy Molyneux; Mike English; Susan Cleary
Journal:  Int J Health Policy Manag       Date:  2015-09-16

4.  Surgical process improvement tools: defining quality gaps and priority areas in gastrointestinal cancer surgery.

Authors:  A C Wei; K S Devitt; M Wiebe; O F Bathe; R S McLeod; D R Urbach
Journal:  Curr Oncol       Date:  2014-04       Impact factor: 3.677

Review 5.  Setting healthcare priorities in hospitals: a review of empirical studies.

Authors:  Edwine W Barasa; Sassy Molyneux; Mike English; Susan Cleary
Journal:  Health Policy Plan       Date:  2014-03-05       Impact factor: 3.344

6.  Introduction and adoption of innovative invasive procedures and devices in the NHS: an in-depth analysis of written policies and qualitative interviews (the INTRODUCE study protocol).

Authors:  Sian Cousins; Hollie Richards; Jesmond Zahra; Daisy Elliott; Kerry Avery; Harry F Robertson; Sangeetha Paramasivan; Nicholas Wilson; Johnny Mathews; Zoe Tolkien; Barry G Main; Natalie S Blencowe; Robert Hinchliffe; Jane M Blazeby
Journal:  BMJ Open       Date:  2019-08-26       Impact factor: 2.692

7.  Discussing surgical innovation with patients: a qualitative study of surgeons' and governance representatives' views.

Authors:  Jesmond Zahra; Sangeetha Paramasivan; Natalie S Blencowe; Sian Cousins; Kerry Avery; Johnny Mathews; Barry G Main; Angus G K McNair; Robert Hinchliffe; Jane M Blazeby; Daisy Elliott
Journal:  BMJ Open       Date:  2020-11-06       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.